scispace - formally typeset
S

Sonny Bal

Researcher at University of Missouri

Publications -  9
Citations -  317

Sonny Bal is an academic researcher from University of Missouri. The author has contributed to research in topics: Osteoarthritis & Synovial fluid. The author has an hindex of 5, co-authored 9 publications receiving 269 citations.

Papers
More filters
Journal ArticleDOI

Clinical fracture of cross-linked UHMWPE acetabular liners.

TL;DR: It is believed that cross-linked UHMWPE remains an excellent bearing material for total hip replacements but that designs employing this material should mitigate stress concentrations or other design features that increase the risk of fracture.
Journal ArticleDOI

Bioactive silicon nitride: A new therapeutic material for osteoarthropathy.

TL;DR: New insights are obtained into the biological interactions between Si3N4 and living cells, as a consequence of the off-stoichiometric chemical nature of its surface at the nanometer scale and it is suggested that Si3n4 might provide unique new medicinal therapies and effective remedies for various bone or joint maladies and diseases.
Journal ArticleDOI

Identification of Synovial Fluid Biomarkers for Knee Osteoarthritis and Correlation with Radiographic Assessment.

TL;DR: Evaluated synovial fluid from knees with and without OA for potential markers of joint inflammation and degradation and to correlate these findings with radiographic severity of disease provide novel and clinically relevant information for the investigation of synovIAL fluid biomarkers for knee OA.
Journal ArticleDOI

In vitro antibacterial activity of oxide and non-oxide bioceramics for arthroplastic devices: I. In situ time-lapse Raman spectroscopy

TL;DR: This study examined the bacteriostatic response of two bioceramic materials commonly employed as prosthetic implants and found that non-oxide Si3N4 possesses an inherently anti-infective surface chemistry, which acts in a responsive way against bacterial loading.
Journal ArticleDOI

Biological response of human osteosarcoma cells to Si3N4-doped Bioglasses

TL;DR: In this article, commercial 45S5 Bioglass® powder was mixed with 5 and 10 µmol% Si3N4 powder, followed by melting, cooling, crushing, and comminution.